1.46
-0.085(-5.52%)
Currency In USD
| Previous Close | 1.54 |
| Open | 1.54 |
| Day High | 1.71 |
| Day Low | 1.42 |
| 52-Week High | 5.08 |
| 52-Week Low | 1.42 |
| Volume | 1.9M |
| Average Volume | 1.98M |
| Market Cap | 87.23M |
| PE | -1.12 |
| EPS | -1.3 |
| Moving Average 50 Days | 2.88 |
| Moving Average 200 Days | 3.18 |
| Change | -0.09 |
If you invested $1000 in Eledon Pharmaceuticals, Inc. (ELDN) 10 years ago, it would be worth $0.79 as of November 19, 2025 at a share price of $1.455. Whereas If you bought $1000 worth of Eledon Pharmaceuticals, Inc. (ELDN) shares 5 years ago, it would be worth $75.58 as of November 19, 2025 at a share price of $1.455.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Eledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
GlobeNewswire Inc.
Yesterday at 9:05 PM GMT
IRVINE, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced preliminary results from an investigator-initiated trial conducted at the University of Chicago Medicine’s Transplant Institute
Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire Inc.
Nov 12, 2025 12:56 PM GMT
IRVINE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced the pricing of its underwritten public offering of (i) 15,152,485 shares of its common stock at a public offering price of $1.
Eledon Pharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire Inc.
Nov 11, 2025 10:26 PM GMT
IRVINE, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that it has commenced an underwritten public offering of shares of its common stock and, in lieu of common stock to certain in